التفاصيل البيبلوغرافية
| العنوان: |
Rapid Development of Graves' Ophthalmopathy After Treatment With Ipilimumab and Recurrence With Pembrolizumab in a Patient With Previously Treated Graves' Disease. |
| المؤلفون: |
Rhea, Logan1, Yoon, Ji Won1, Jang, Sekwon1 |
| المصدر: |
Journal of Oncology Practice. Dec2018, Vol. 14 Issue 12, p747-749. 4p. |
| مصطلحات موضوعية: |
*PREDNISONE, *AGE factors in disease, *GRAVES' disease, *COMPUTED tomography, *DIARRHEA, *DOSE-effect relationship in pharmacology, *LUNG tumors, *MELANOMA, *METASTASIS, *MONOCLONAL antibodies, *ORAL drug administration, *THYROID eye disease, *THYROTROPIN, *THYROXINE, *TUMOR classification, *VISUAL acuity, *DISEASE relapse, *TERMINATION of treatment, *SEVERITY of illness index, *IPILIMUMAB, *DIAGNOSIS, *THERAPEUTICS |
| مستخلص: |
The article presents a case study of an 83-year-old man who developed Graves' ophthalmopathy after he was treated with the drugs ipilimumab and pembrolizumab. The patient, who had a history of Graves' disease, received ipilimumab for treating melanoma of the arm, and pembrolizumab was administered to him for treating lung metastasis. It discusses the actions of immune checkpoint inhibitors and their potential adverse effects on patients with preexisting Graves' disease. |
| قاعدة البيانات: |
Academic Search Index |
Full Text Finder